AGAdam J. Gormley

Adam J. Gormley

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adam J. Gormley has a total of 138 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • High-Throughput Polymer Design for the Biological Interface

    by Supraja S. Chittari, Adam J. Gormley

    High-throughput experimentation is transforming synthetic polymer design for biological applications, enabling data-driven approaches that map the vast chemical design space accessible to synthetic macromolecules. In this Viewpoint, we survey recent advances in high-throughput methodologies for discovering polymers that interface with biological systems. We first review synthetic strategies, such as well-plate polymerizations, immobilized and solid-phase synthesis, and continuous flow chemistry, that enable parallelized, miniaturized access to large polymer libraries. We then discuss screening methods for structural characterization, target-binding interactions, and functional performance in cellular and biological contexts. We highlight how these readouts capture the disordered, dynamic nature of synthetic polymers relative to structured biomacromolecules. Finally, we examine how machine learning, active learning, self-driving laboratories, and emerging agentic AI tools are being integrated with high-throughput workflows to accelerate inverse design and autonomous experimentation. We underscore the potential of increasingly automated discovery in future years and the need for rigorous, application-appropriate workflow design. Together, these synthesis, characterization, and computational strategies form a synergistic pipeline poised to accelerate the discovery of next-generation polymer therapeutics and biomaterials.

  • Open Access

    Automation and Active Learning for the Multi‐Objective Optimization of Antibody Formulations

    by D. Christopher Radford, Matthew Tamasi, Elena Di Mare, Adam J. Gormley

    Over the last forty years, monoclonal antibodies have become increasingly important therapeutic agents, with most manufactured as preformulated solutions. However, bioformulation of complex proteins is a difficult engineering challenge; formulations must be tailored to individual therapies, necessitating time‐ and material‐intensive campaigns to select combinations of excipients to simultaneously optimize various design criteria. These additives complicate formulation design with unintuitive and non‐linear relationships, creating a vast multidimensional design space that is intrinsically difficult to optimize using traditional techniques. To address this challenge, we investigated a high‐throughput discovery pipeline using machine learning to model and predict the effects of GRAS excipients on formulation behavior of a model antibody. This was supported by automation‐assisted “on‐demand” formulation to produce dozens of uniquely formulated antibody solutions for downstream evaluation and biophysical characterization. This pipeline was then integrated into an iterative closed‐loop cycle of automated Design‐Build‐Test‐Learn (DBTL), where new rounds of experiments are designed by the model. The process yielded both improved formulations and accurate predictive models of formulation behavior across multiple target objectives (melting temperature, diffusivity, and high‐concentration viscosity). This validates the utility of this technique to both map the underlying property‐function landscape and effectively guide formulation development while balancing multiple competing design requirements.


  • Open Access

    Self-driving lab for the data-driven design of single-chain polymer nanoparticles

    by Alexander Suponya, Elena Di Mare, Cesar Ramírez, Apostolos Maroulis, Dylan Waynor, Cristian López, D. Christopher Radford, Adam J. Gormley

  • Open Access

    A user's guide to your first self-driving liquid handling lab

    by Apostolos P. Maroulis, Dylan M. Waynor, Quinn M. Gallagher, Roshan A. Patel, Matthew Tamasi, D. Christopher Radford, Michael A. Webb, Adam J. Gormley

    To contribute towards the democratization of self-driving laboratories, we created a foundation-level guide focusing on Bayesian optimization driven experimentation and low-cost open-source automated liquid handlers.


  • Open Access

    Gene Delivery Mediated by Backbone-Degradable RAFT Copolymers

    by Prajakatta B. Mulay, D. Christopher Radford, Brayan Rondon, Bruna Favetta, Benjamin S. Schuster, Jia Niu, Adam J. Gormley

    Cationic polymers present an attractive platform for gene delivery. However, these highly charged macromolecules can also lead to cytotoxicity. Therefore, there is a strong unmet need to develop efficacious polymeric gene delivery vehicles with high biocompatibility. Here, we leverage recent advances in polymer chemistry to develop backbone-degradable cationic copolymers and evaluate their potential as gene delivery vehicles. Specifically, polycations were prepared via copolymerization with macrocyclic allylic sulfides, which can participate in PET-RAFT polymerization via radical ring-opening cascade copolymerization to install degradable backbone segments. A polymer library with varying degradabilities was prepared and evaluated using a model GFP plasmid to transfect U-2 OS cells. Incorporation of degradable groups into the copolymer backbone improved transfection efficiency 10-fold at low amine/phosphate (N/P) ratios without increasing cytotoxicity, thereby enhancing their value as gene delivery carriers. We hypothesize that degradability may enhance the complex's disassembly kinetics in the cytosol, enabling more efficient payload release.

  • Top Cited Papers
    Open Access

    Automated active learning to optimize hydrogel drug release profiles

    by Eugene Cheong, D. Christopher Radford, Adam J. Gormley


  • Open Access

    A User's Guide to Your First Self-Driving Liquid Handling Lab

    by Apostolos Maroulis, Dylan Waynor, Quinn Gallagher, Roshan Patel, Matthew Tamasi, D. Christopher Radford, Michael Webb, Adam Gormley

    Experimentation is inherently difficult because most methods require substantial refinement, calibration, and validation before high-quality, reliable data can be collected. In most cases, experimental outcomes are impacted by multiple variables, thus requiring their simultaneous optimization for single and multi-objective targets. Traditional experimental approaches rely on trial-and-error methods guided by rational decision making, but these become increasingly inefficient and ineffective as complex interactions between inputs limit our ability to capture underlying trends using conventional statistical approaches. Machine learning and active learning (ML/AL) combined with automation represents an approach that can bolster future laboratory productivity. However, a steep initial learning curve and high costs of instrumentation pose substantial barriers to adoption. To democratize access, we herein comprehensively cover both the computational skills and hardware implementation necessary for self-driven experimental workflows. The accompanying open-source, low-cost liquid handling platforms offer practical templates for researchers adopting self-driving lab (SDL) methodologies. Complete tutorials and build guides are provided at https://gormleylab.github.io/SDLGuide.

  • Open Access

    Automation and Active Learning for the Multi-Objective Optimization of Antibody Formulations

    by D. Christopher Radford, Matthew Tamasi, Elena Di Mare, Adam Gormley

    Over the last forty years, biologics such as monoclonal antibodies have become an increasingly important therapeutic agent in the treatment of numerous diseases. Between 1986 and 2025, over 200 antibody-based treatments have been approved globally, most of which are manufactured as preformulated solutions for subsequent administration to patients. However, bioformulation of complex proteins is a difficult engineering challenge; formulations must be tailored to individual therapies, necessitating time- and material-intensive campaigns to select a combination of excipients to simultaneously optimize an array of design criteria. These many interacting additives complicate formulation design with unintuitive and non-linear relationships, thus creating a vast and multidimensional design space that is intrinsically difficult to optimize using traditional techniques. To address this challenge, we investigated a high-throughput discovery pipeline using machine learning to model and predict formulation behavior of Generally Recognized as Safe (GRAS) excipients on a model antibody. This was supported by automation-assisted “on-demand” formulation to produce dozens of uniquely formulated antibody solutions with high reproducibility for downstream evaluation and biophysical characterization. This pipeline was then integrated into an iterative closed-loop cycle of automated Design-Build-Test-Learn (DBTL), where new rounds of experiments are designed by the ML model. The process yielded both optimized formulations as well as highly accurate predictive models of formulation behavior. This validates the utility of this technique to both map the underlying property-function landscape and effectively guide formulation development while balancing multiple competing design requirements.


  • Open Access

    Self-driving lab for the data-driven design of single-chainpolymer nanoparticles

    by Alexander Suponya, Elena Di Mare, Cesar Ramirez, Apostolos Maroulis, Dylan Waynor, Cristian Lopez, D. Christopher Radford, Adam Gormley

    Careful mapping of protein structure-activity relationships connecting amino acid sequence to its tertiary structure has spurred the rise of rational protein design using computational and experimental methods. Drawing inspiration from proteins for synthetic materials, careful choice of monomers enables the creation of novel single-chain polymer nanoparticles (SCNPs) with self-assembling characteristics. Rationally designed SCNPs permit the necessary structural complexity for use as protein mimics and polymer-protein hybrids, while granting access to a broad chemical design space, straightforward preparation, and tunable properties. Advances in oxygen-tolerant photoinduced polymerization chemistries have greatly facilitated efficient preparation of SCNPs. Here, we describe a high-throughput, autonomous workflow for active learning to discover structure-property relationships and use them to iteratively predict and synthesize novel SCNPs. We developed a control system consisting of a liquid handling robot to mix polymerization reagents, a custom-built lightbox to catalyze PET-RAFT polymerization, a dynamic light scattering (DLS) plate reader to characterize polymer hydrodynamic radius (Rh), and a robotic arm to transport polymer-containing well plates from one instrument to another. By first testing low-feature, rationally designed polymer libraries, we gained experimental context for the development of higher-feature, randomly sampled seed libraries as training sets for Gaussian process regressor (GPR) models. Over multiple generations of Bayesian optimization (BO), additional generations of polymer synthesis were found not only to successfully improve model performance but also to represent the impact of specific monomer content on Rh. This automated polymer discovery platform serves as a useful prototype for SCNP design using more complex design features as well as more advanced optimization targets, including polymers whose structure can be tailored for enzyme stabilization and other biomedical applications.

  • Open Access

    Gene Delivery Mediated by Backbone-Degradable RAFT Copolymers

    by Prajakatta B. Mulay, D. Christopher Radford, Brayan Rondon, Bruna Favetta, Benjamin S. Schuster, Jia Niu, Adam J. Gormley

    Cationic polymers present an attractive platform for gene delivery. However, these highly charged macromolecules can also lead to cytotoxicity. Therefore, there is a strong unmet need to develop efficacious polymeric gene delivery vehicles with high biocompatibility. Here, we leveraged recent advances in polymer chemistry to develop backbone-degradable cationic copolymers and evaluate their potential as gene delivery vehicles. Specifically, polycations were prepared via copolymerization with macrocyclic allylic sulfides which can participate in PET-RAFT polymerization via radical ring-opening cascade copolymerization to install degradable backbone segments. A polymer library with varying degradability was prepared and evaluated using a model GFP plasmid to transfect U-2 OS cells. Incorporation of degradable groups into the copolymer backbone improved transfection efficiency 10-fold at low amine/phosphate (N/P) ratios without increasing cytotoxicity, thereby enhancing their value as gene delivery carriers. We hypothesize that degradability may enhance the complex’s disassembly kinetics in the cytosol, enabling more efficient payload release.